Teva Pharmaceutical Industries Ltd. launched its first new product of the new year Tuesday with the launch of its generic equivalent an oral contraceptive used by women to prevent pregnancy.
The product, which Teva (NYSE: TEVA) is selling in a 28-day blister pack dispenser in the United States, is a generic version of Janssen Pharmaceuticals Ortho Try-Cyclen Lo tablets.
Read the full story here.
Breaking news and the stories that matter to your neighborhood.
Read more business news on Philadelphia Business Journal website.